Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · IEX Real-Time Price · USD
1.020
+0.062 (6.52%)
At close: Jul 19, 2024, 4:00 PM
1.010
-0.010 (-0.98%)
Pre-market: Jul 22, 2024, 7:28 AM EDT
Ovid Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Ovid Therapeutics stock have an average target of 4.04, with a low estimate of 1.20 and a high estimate of 8.00. The average target predicts an increase of 296.08% from the current stock price of 1.02.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OVID stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 5 | 4 | 3 | 3 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +194.12% | Jul 2, 2024 |
| BTIG | BTIG | Strong Buy Maintains $11 → $5 | Strong Buy | Maintains | $11 → $5 | +390.20% | Jun 18, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $9 → $3 | Strong Buy | Maintains | $9 → $3 | +194.12% | Jun 18, 2024 |
| Citigroup | Citigroup | Hold Maintains $3.5 → $1.2 | Hold | Maintains | $3.5 → $1.2 | +17.65% | Jun 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $3 | Strong Buy | Maintains | $9 → $3 | +194.12% | Jun 18, 2024 |
Financial Forecast
Revenue This Year
2.33M
from 391.70K
Increased by 495.36%
Revenue Next Year
59.39M
from 2.33M
Increased by 2,446.61%
EPS This Year
-0.86
from -0.74
EPS Next Year
-0.29
from -0.86
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 17.3M | 188.4M | 43.3M | 84.6M | 169.1M |
| Avg | 2.3M | 59.4M | 27.2M | 27.4M | 72.0M |
| Low | 98,000 | 774,200 | 10.7M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4,311.9% | 7,977.6% | -27.1% | 211.5% | 516.9% |
| Avg | 495.4% | 2,446.6% | -54.2% | 0.9% | 162.6% |
| Low | -75.0% | -66.8% | -81.9% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.76 | 1.47 | -0.29 | -0.43 | -0.43 |
| Avg | -0.86 | -0.29 | -0.84 | -0.42 | -0.42 |
| Low | -1.01 | -0.97 | -1.64 | -0.40 | -0.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.